{
    "organizations": [],
    "uuid": "dd83cb0e57494be5e8e8a7a5084df55ac8df08d3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-continues-to-monitor-advers/brief-u-s-fda-continues-to-monitor-adverse-events-connected-with-essure-idUSFWN1QP0VZ",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Continues To Monitor Adverse Events Connected With Essure",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - U.S. Food And Drug Administration:\n* U.S. FDA SAYS AT CURRENT TIME, IS ACTIVELY EVALUATING A COLLECTION OF NEW MEDICAL DEVICE REPORTS SUBMITTED TO FDA ON ESSURE DEVICE\n* U.S FDA SAYS OF THE NEARLY 12,000 REPORTS RECEIVED IN 2017 FOR ESSURE, THE MAJORITY WERE SENT TO FDA IN LAST QUARTER OF THE YEAR\n* U.S. FDA SAYS CONTINUES TO BELIEVE THAT ESSURE MAY BE APPROPRIATE FOR SOME WOMEN BASED ON FDA’S CURRENT INFORMATION\n* U.S. FDA SAYS ALSO RECOGNIZES THAT “SERIOUS PROBLEMS” HAVE BEEN ASSOCIATED WITH USE OF ESSURE\n* U.S. FDA SAYS CONTINUING TO MONITOR ADVERSE EVENTS CONNECTED WITH ESSURE REPORTED TO FDA’S DATABASE, AS WELL AS OTHER DATA SOURCES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T03:56:00.000+02:00",
    "crawled": "2018-03-08T17:37:09.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "say",
        "current",
        "time",
        "actively",
        "evaluating",
        "collection",
        "new",
        "medical",
        "device",
        "report",
        "submitted",
        "fda",
        "essure",
        "device",
        "fda",
        "say",
        "nearly",
        "report",
        "received",
        "essure",
        "majority",
        "sent",
        "fda",
        "last",
        "quarter",
        "year",
        "fda",
        "say",
        "continues",
        "believe",
        "essure",
        "may",
        "appropriate",
        "woman",
        "based",
        "fda",
        "current",
        "information",
        "fda",
        "say",
        "also",
        "recognizes",
        "serious",
        "problem",
        "associated",
        "use",
        "essure",
        "fda",
        "say",
        "continuing",
        "monitor",
        "adverse",
        "event",
        "connected",
        "essure",
        "reported",
        "fda",
        "database",
        "well",
        "data",
        "source",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}